1. Yu, Yang, Cao, Wen-Ming, Cheng, Feng, Zhang, Chunchao, Zhang, Hong. 2024. FOXK2 amplification promotes breast cancer development and chemoresistance. In Cancer letters, 597, 217074. doi:10.1016/j.canlet.2024.217074. https://pubmed.ncbi.nlm.nih.gov/38901667/
2. Zhang, Yaqi, Wang, Yinu, Zhao, Guangyuan, Adli, Mazhar, Matei, Daniela. . FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway. In The Journal of clinical investigation, 132, . doi:10.1172/JCI151591. https://pubmed.ncbi.nlm.nih.gov/35349489/
3. Yu, Yang, Cao, Wen-Ming, Cheng, Feng, Zhang, Chunchao, Zhang, Hong. 2023. FOXK2 amplification and overexpression promotes breast cancer development and chemoresistance. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.05.28.542643. https://pubmed.ncbi.nlm.nih.gov/37398114/
4. Wang, Xi-Wen, Guo, Qi-Qiang, Yu, Yang, Zhao, Jun-Gang, Cao, Liu. 2021. The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin. In Journal of cellular and molecular medicine, 26, 491-506. doi:10.1111/jcmm.17107. https://pubmed.ncbi.nlm.nih.gov/34866322/
5. Li, Yingge, Chen, Jie, Wang, Bin, Pei, Huadong, Yao, Yi. 2023. FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis. In Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 67, 100926. doi:10.1016/j.drup.2023.100926. https://pubmed.ncbi.nlm.nih.gov/36682222/
6. Zhang, Cancan, Xu, Yinyin, Zhu, Xinyue, Shi, Tingyan, Zhang, Rong. 2024. Phosphorylation of FOXK2 at Thr13 and Ser30 by PDK2 sustains glycolysis through a positive feedback manner in ovarian cancer. In Oncogene, 43, 1985-1999. doi:10.1038/s41388-024-03052-x. https://pubmed.ncbi.nlm.nih.gov/38734828/
智鼠故事 
